FDA advisers recommend J&J booster shot after at least two months to recipients 18 and older
The agency's Vaccines and Related Biological Products Advisory Committee voted unanimously
Food and Drug Administration advisers voted unanimously Friday to recommend a booster dose of Johnson & Johnson's vaccine at least two months after patients get their first dose.
The agency's Vaccines and Related Biological Products Advisory Committee voted recommend the extra dose for all recipients of the J&J Janssen vaccine who are 18 and older, according to CNN.
The adviser in the recommendation also asked to simplify the original question being posed by the FDA, which was to answer whether the data showed that waiting six months or longer after getting the first shot would provide an even stronger immune response.
The Centers for Disease Control and Prevention's vaccine advisers will be asked to consider the recommendation after the FDA, CNN also reports.
Johnson & Johnson says studies show a booster at two or six months can increase vaccine effectiveness to up to 94%,
News, not Noise
- Trump flexes his muscle again with primary wins, as Dr. Oz race ends as a cliffhanger
- Major funder of Wuhan lab told Fauci's agency COVID would end at 20,000 cases
- Juror donations, judge’s family ties at Sussmann trial spotlight DC's liberal leanings
- Rep. Cawthorn loses North Carolina GOP House primary, concedes race
- Election integrity: Wisconsin judge questions Zuckerbucks lawsuit